XENOTHERA is developing a technological platform of exclusive “glyco-humanized” antibodies built on dual expertise in genetics and immunology. The financing... View Article
Author Archives for Adeline Chauvigné
French biotech XENOTHERA accelerates its development with fundraising of 20 million euros
26 April 2024XENOTHERA is developing a technological platform of exclusive “glyco-humanized” antibodies built on dual expertise in genetics and immunology. The financing... View Article
OSE Immunotherapeutics announces manufacturing agreement with Cenexi for clinical batches of CoVepiT, OSE’s multi-target second-generation COVID-19 vaccine
OSE Immunotherapeutics and Cenexi, a French contract development and manufacturing organization (CDMO), today announced the signature of an agreement whereby... View Article
OSE Immunotherapeutics announces manufacturing agreement with Cenexi for clinical batches of CoVepiT, OSE’s multi-target second-generation COVID-19 vaccine
26 April 2024OSE Immunotherapeutics and Cenexi, a French contract development and manufacturing organization (CDMO), today announced the signature of an agreement whereby... View Article
GlioCure strengthens its management team with the recruitment of Dr. Sandrine Courtès as Director of Preclinical Development and Intellectual Property
GlioCure SA, a biotechnology company specializing in neuro-oncology, announces the arrival of Dr. Sandrine Courtès, a researcher-entrepreneur dedicated to brain... View Article
GlioCure strengthens its management team with the recruitment of Dr. Sandrine Courtès as Director of Preclinical Development and Intellectual Property
26 April 2024GlioCure SA, a biotechnology company specializing in neuro-oncology, announces the arrival of Dr. Sandrine Courtès, a researcher-entrepreneur dedicated to brain... View Article
InFlectis BioScience licenses rights to a potential new class of therapies for demyelinating diseases from the University of Chicago
InFlectis BioScience has been granted exclusive patent rights from the University of Chicago to use a family of small molecules for the treatment... View Article
InFlectis BioScience licenses rights to a potential new class of therapies for demyelinating diseases from the University of Chicago
26 April 2024InFlectis BioScience has been granted exclusive patent rights from the University of Chicago to use a family of small molecules for the treatment... View Article
Jessica Walker has been elected Board Member of the Council of European Bioregions!
Atlanpole Biotherapie’s European project manager Jessica Walker has been elected Board Member of the Council of European Bioregions! This European... View Article
Jessica Walker has been elected Board Member of the Council of European Bioregions!
26 April 2024Atlanpole Biotherapie’s European project manager Jessica Walker has been elected Board Member of the Council of European Bioregions! This European... View Article
Oncology: infrared light could help surgeons see more clearly the tumors during operations
The University Medical Center Groningen and Kaer Labs announce entering into a research collaboration to evaluate NIR-II fluorescence for biological... View Article
Oncology: infrared light could help surgeons see more clearly the tumors during operations
26 April 2024The University Medical Center Groningen and Kaer Labs announce entering into a research collaboration to evaluate NIR-II fluorescence for biological... View Article
New partner | 2 do it
Engaged in relational performance in business, Lucie Léger strongly believes that we can transform businesses and employees ! Reinvent relational... View Article
New partner | 2 do it
26 April 2024Engaged in relational performance in business, Lucie Léger strongly believes that we can transform businesses and employees ! Reinvent relational... View Article
New partner | SinnRJ
SinnRJ’s core activity is to support innovative structures (SMEs, large groups, academic laboratories) in obtaining regional, French and especially European... View Article
New partner | SinnRJ
26 April 2024SinnRJ’s core activity is to support innovative structures (SMEs, large groups, academic laboratories) in obtaining regional, French and especially European... View Article
New partner | Strategiqual
Strategiqual is a leading consultancy organization highly skilled for drugs, medical devices and in vitro medical devicesprojects. Strategiqual provides companies... View Article
New partner | Strategiqual
26 April 2024Strategiqual is a leading consultancy organization highly skilled for drugs, medical devices and in vitro medical devicesprojects. Strategiqual provides companies... View Article
New partner | Alison Munro
25+ years dedicated to Health innovation. Founded Alison Munro Corporate Language (AMCL) in 2005. Has coached 350+ startups & top-notch... View Article
New partner | Alison Munro
26 April 202425+ years dedicated to Health innovation. Founded Alison Munro Corporate Language (AMCL) in 2005. Has coached 350+ startups & top-notch... View Article